| Description | Moxestrol is a synthetic agonist of estrogen. It is a medication that is or was utilized in Europe for the treatment of menopausal symptoms and menstrual disorders. |
| Synonyms | RU 2858, R 2858 |
| molecular weight | 326.43 |
| Molecular formula | C21H26O3 |
| CAS | 34816-55-2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. De Boer W, Snippe L, Ab G, Gruber M. Estrogen receptor in avian embryo and adult liver: estrogen receptor activation and dissociation kinetics of estradiol, ethynylestradiol, and moxestrol. Endocrinology. 1982 Apr;110(4):1217-24. PubMed PMID: 7060523. 2. Salmon J, Coussediere D, Cousty C, Raynaud JP. Pharmacokinetics and metabolism of moxestrol in humans. J Steroid Biochem. 1983 May;18(5):565-73. PubMed PMID: 6855232. 3. Salmon J, Coussediere D, Cousty C, Raynaud JP. Pharmacokinetics and metabolism of moxestrol in animals--rat, dog and monkey. J Steroid Biochem. 1983 Aug;19(2):1223-34. PubMed PMID: 6887930. 4. Blom MJ, Wassink MG, Kloosterboer HJ, Ederveen AG, Lambert JG, Goos HJ. Metabolism of estradiol, ethynylestradiol, and moxestrol in rat uterus, vagina, and aorta: influence of sex steroid treatment. Drug Metab Dispos. 2001 Jan;29(1):76-81. PubMed PMID: 11124233. |